Form 4 for NUTX Nutex Health Inc.
Accepted 2025-04-14 00:00:00 ET · period of report 2025-03-01 · accession 0001486189-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-14 | 2025-04-04 | NUTX | Luqman Elisa V | CLO - SEC | F - Tax | $72.10 | -266 | 1,070 | -20% | -$19.2K |
| D | 2025-04-14 | 2025-03-01 | NUTX | Luqman Elisa V | CLO - SEC | M - OptEx | $0.00 | +1,250 | 1,336 | +1,453% | $0 |
| D | 2025-04-14 | 2025-03-10 | NUTX | Luqman Elisa V | CLO - SEC | M - OptEx | $0.00 | +2,500 | 5,000 | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-04 | F | D | 266 | $72.10 | 1,070 | D | — | — | (F2) Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations. (F3) The Reporting Person directly owns 1,060 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 1,070 shares. |
| 2 | Common | Common Stock | 2025-03-01 | M | A | 1,250 | $0.00 | 1,336 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2025-03-10 | M | A | 2,500 | $0.00 | 5,000 | D | $0.00 · 2026-03-01 to 2028-03-01 | 2,500 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. |